Orsnn
Financial Software · Washington, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
2608 2nd Ave PMB 501, Seattle, Washingto...Website
www.orsnn.comRevenue
<$5 MillionIndustry
About Orsnn
ORSNN is a digital loan trading platform designed for institutional clients, offering a comprehensive infrastructure for buying and selling loans across various asset classes. The platform features advanced analytics, a brokerless marketplace, and embedded due diligence capabilities, streamlining the trading process and reducing costs. Targeting credit unions, banks, dealers, and credit funds, ORSNN aims to transform capital markets with efficient workflows and faster transaction times. By eliminating outdated processes, ORSNN enhances the trading experience and facilitates informed decision-making.Explore more
Orsnn Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Orsnn
Compare insights from companies similar to Orsnn, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Orsnn Tech Stack
A closer look at the technologies used by Orsnn
See more technologies
Top Financial Software Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Orsnn
Sign Up For FreeTo access detailed company insights
ORSNN is a digital loan trading platform designed for institutional clients, offering a comprehensive infrastructure for buying and selling loans across various asset classes. The platform features advanced analytics, a brokerless marketplace, and embedded due diligence capabilities, streamlining the trading process and reducing costs. Targeting cr... Read More
